arrow
M

Max Schlaak

charite - universitätsmedizin berlin
H指数:56
被引数:1.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Komplette Lymphknotendissektion versus selektive Lymphknotenexstirpation bei Melanompatienten mit nodaler Makrometastasierung und adjuvanter Systemtherapie

对于黑色素瘤患者伴有结节性巨转移和辅助全身治疗,完全淋巴结清扫术与选择性淋巴结切除的比较

2026-09-060
OAAI
Real-world management of adjuvant systemic melanoma therapy: Multi-center survey of 51 DeCOG skin cancer centers

黑色素瘤辅助全身治疗的实际管理:DeCOG 皮肤肿瘤中心51个中心的调查

2025-11-010
OAAI
HIGH-GRADE IMMUNE-RELATED ADVERSE EVENTS AND PATIENT OUTCOMES FOLLOWING POST-OPERATIVE CHECKPOINT INHIBITION IN RESECTED BRAIN METASTASES: A RETROSPECTIVE COHORT STUDY

高级别免疫相关不良事件及术后检查点抑制剂治疗切除脑转移瘤患者的预后:一项回顾性队列研究

2025-10-010
PRE
Targeted Therapy for Rare BRAF-Mutated Melanoma: Updated Multicenter Analysis and Launch of a Publicly Accessible Online Outcome Database

靶向治疗罕见BRAF突变黑色素瘤:更新后的多中心分析及公共可访问在线结局数据库的建立

2025-08-090
PRE
Real-World Pattern-of-Care Analysis of Primary Cutaneous Lymphomas Radiation Therapy Among European Organisation for Research and Treatment of Cancer Members

欧洲癌症研究与治疗组织成员对原发性皮肤淋巴瘤放疗的真实世界模式分析

2025-03-010
OAAI
Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma

在免疫检查点抑制下对晚期黑色素瘤完全缓解的患者进行真实世界管理

2025-01-020
OAAI
S2k guideline basal cell carcinoma of the skin (update 2023)
2024-12-080
OAAI
S2k guideline basal cell carcinoma of the skin (update 2023)
2024-11-250
OAAI
Prospective multicenter study using artificial intelligence to improve dermoscopic melanoma diagnosis in patient care

使用人工智能改善患者护理中皮肤镜黑色素瘤诊断的前瞻性多中心研究

2024-09-112
OA
Patients' and dermatologists' preferences in artificial intelligenceedriven skin cancer diagnostics: A prospective multicentric survey study

患者和皮肤科医生在人工智能驱动的皮肤癌诊断中的偏好: 一项前瞻性多中心调查研究

2024-08-011
OAAI
Using multiple real-world dermoscopic photographs of one lesion improves melanoma classification via deep learning
2024-05-011
OAAI